NASDAQ:DXTR - Dextera Surgical Stock Price, Price Target & More

$0.0371 0.00 (-2.11 %)

(As of 04/20/2018 12:12 PM ET)

Previous Close$0.0379

Today's Range$0.0371 - $0.0390

52-Week Range$0.0175 - $1.24

Volume531,881 shs

Average Volume443,994 shs

Market Capitalization$3.02 million

P/E RatioN/A

Dividend YieldN/A

Beta-1.63

About Dextera Surgical (NASDAQ:DXTR)

Dextera Surgical Inc., formerly Cardica, Inc., designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons. Its MicroCutter 5/80 is a commercially available cartridge-based microcutter device with approximately five millimeter shaft diameter, over 80 degrees of articulation, and an approximately 30 millimeter staple line cleared for specified indications for use in the United States, and in the European Union (EU) for a range of indications for use. It designs, manufactures and markets automated anastomotic systems used by surgeons to perform anastomoses during on- or off-pump coronary artery bypass graft procedures and these products include the C-Port xA system, the C-Port Flex A system and the PAS-Port Proximal Anastomosis System.

Receive DXTR News and Ratings via Email

Sign-up to receive the latest news and ratings for DXTR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A

Sub-IndustryN/A

SectorN/A

SymbolNASDAQ:DXTR

CUSIPN/A

Webwww.dexterasurgical.com

Phone+1-650-3649975

Debt

Debt-to-Equity RatioN/A

Current Ratio0.47%

Quick Ratio0.37%

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$3.42 million

Price / Sales0.52

Cash FlowN/A

Price / CashN/A

Book Value($0.21) per share

Price / Book-0.18

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$-17,220,000.00

Net Margins-402.96%

Return on EquityN/A

Return on Assets-195.83%

Miscellaneous

Employees50

Outstanding Shares48,210,000

How to Become a New Pot Stock Millionaire

Dextera Surgical (NASDAQ:DXTR) Frequently Asked Questions

What is Dextera Surgical's stock symbol?

Dextera Surgical trades on the NASDAQ under the ticker symbol "DXTR."

How were Dextera Surgical's earnings last quarter?

Dextera Surgical Inc (NASDAQ:DXTR) issued its quarterly earnings results on Thursday, November, 9th. The medical instruments supplier reported ($0.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.07) by $0.02. The medical instruments supplier had revenue of $0.69 million for the quarter, compared to the consensus estimate of $0.62 million. View Dextera Surgical's Earnings History.

When is Dextera Surgical's next earnings date?

Dextera Surgical is scheduled to release their next quarterly earnings announcement on Thursday, May, 3rd 2018. View Earnings Estimates for Dextera Surgical.

What price target have analysts set for DXTR?

2 brokerages have issued 1 year price targets for Dextera Surgical's stock. Their predictions range from $0.70 to $0.80. On average, they expect Dextera Surgical's share price to reach $0.75 in the next year. View Analyst Ratings for Dextera Surgical.

Who are some of Dextera Surgical's key competitors?

Some companies that are related to Dextera Surgical include Rex Energy (REXX), STRATA Skin Sciences (SSKN), Avinger (AVGR), Westmoreland Coal (WLB), Orexigen Therapeutics (OREX), Sorrento Tech (ROKA), Rosetta Genomics (ROSG), Recon Capital Series Trust Recon Capital FTSE 100 ETF (UK), Global Brokerage (GLBR), Great Basin Scientific (GBSN), Rand Logistics (RLOG), 1st Century Bancshares (FCTY), Accelrys (ACCL), Acme Packet (APKT), Actuate (BIRT), Adept Technology (ADEP), Air Methods (AIRM) and Allos Therapeutics (ALTH).

Who are Dextera Surgical's key executives?

Dextera Surgical's management team includes the folowing people:

Robert Y. Newell IV, Principal Executive Officer, Chief Financial Officer, Vice President - Finance (Age 67)
Michael A. Bates, Director (Age 57)
Julian Nikolchev, Director (Age 62)

Has Dextera Surgical been receiving favorable news coverage?

Media stories about DXTR stock have been trending somewhat positive on Friday, according to Accern Sentiment Analysis. Accern scores the sentiment of media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Dextera Surgical earned a media sentiment score of 0.04 on Accern's scale. They also gave news articles about the medical instruments supplier an impact score of 46.33 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.

How do I buy shares of Dextera Surgical?

Shares of DXTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Dextera Surgical's stock price today?

One share of DXTR stock can currently be purchased for approximately $0.0371.

How big of a company is Dextera Surgical?

Dextera Surgical has a market capitalization of $3.02 million and generates $3.42 million in revenue each year. Dextera Surgical employs 50 workers across the globe.

How can I contact Dextera Surgical?

Dextera Surgical's mailing address is 900 Saginaw Dr, REDWOOD CITY, CA 94063-4753, United States. The medical instruments supplier can be reached via phone at +1-650-3649975 or via email at [email protected]

MarketBeat Community Rating for Dextera Surgical (DXTR)

Community Ranking:		2.7 out of 5 ( )
Outperform Votes:		165 (Vote Outperform)
Underperform Votes:		145 (Vote Underperform)
Total Votes:		310

MarketBeat's community ratings are surveys of what our community members think about Dextera Surgical and other stocks. Vote "Outperform" if you believe DXTR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DXTR will underperform the S&P 500 over the long term. You may vote once every thirty days.

Dextera Surgical (NASDAQ:DXTR) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

2 Wall Street analysts have issued ratings and price targets for Dextera Surgical in the last 12 months. Their average twelve-month price target is $0.75, suggesting that the stock has a possible upside of 1,921.56%. The high price target for DXTR is $0.80 and the low price target for DXTR is $0.70. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	3.00	3.00	3.00	3.00
Ratings Breakdown:	0 Sell Rating(s) 0 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$0.75	$0.75	$0.75	$0.75
Price Target Upside:	1,921.56% upside	200.00% upside	200.00% upside	200.00% upside

Dextera Surgical (NASDAQ:DXTR) Consensus Price Target History

Price Target History for Dextera Surgical (NASDAQ:DXTR)

Dextera Surgical (NASDAQ:DXTR) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
8/16/2017	Ladenburg Thalmann	Initiated Coverage	Buy -> Buy	$0.80	High
7/12/2017	Wedbush	Lower Price Target	Outperform	$3.50 -> $0.70	High

(Data available from 4/20/2016 forward)

Dextera Surgical (NASDAQ:DXTR) Earnings History and Estimates Chart

Earnings by Quarter for Dextera Surgical (NASDAQ:DXTR)

Dextera Surgical (NASDAQ:DXTR) Earnings Estimates

2018 EPS Consensus Estimate: ($0.20)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	1	($0.05)	($0.05)	($0.05)
Q2 2018	1	($0.05)	($0.05)	($0.05)
Q3 2018	1	($0.05)	($0.05)	($0.05)
Q4 2018	1	($0.05)	($0.05)	($0.05)

Dextera Surgical (NASDAQ DXTR) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/3/2018
11/9/2017	Q1 2018	($0.07)	($0.09)	$0.62 million	$0.69 million	View	N/A
8/8/2017	Q4 2017	($0.11)	($0.3950)	$1.03 million	$1.05 million	View	Listen
5/4/2017	Q3 2017	($0.48)	($0.50)	$1.10 million	$1.11 million	View	Listen
2/7/2017	Q217	($0.34)	($0.41)	$0.67 million	$0.80 million	View	Listen
11/7/2016	Q1	($0.48)	($0.44)	$0.61 million	$0.47 million	View	Listen
8/9/2016	Q4	($0.47)	($0.48)	$0.62 million	$0.72 million	View	Listen
5/5/2016	Q3 2016	($0.48)	($0.34)	$0.68 million	$1.89 million	View	N/A
2/4/2016	Q2	($0.05)	($0.05)	$0.73 million	$0.70 million	View	Listen
11/5/2015	Q116	($0.05)	($0.05)	$0.71 million	$0.76 million	View	Listen
8/6/2015	Q415	($0.05)	($0.04)	$0.50 million	$0.70 million	View	Listen
5/6/2015	Q315	($0.05)	($0.05)	$0.54 million	$0.56 million	View	Listen
2/5/2015	Q215	($0.05)	($0.06)	$0.97 million	$0.66 million	View	Listen
11/4/2014	Q1	($0.06)	($0.06)	$1.18 million	$1.07 million	View	Listen
8/7/2014	Q4	($0.06)	($0.08)	$0.93 million	$1.03 million	View	Listen
5/1/2014	Q3 2014	($0.90)	($0.80)	$0.85 million	$0.93 million	View	N/A
2/4/2014	Q2	($0.08)	($0.11)	$0.89 million	$0.85 million	View	Listen
11/4/2013	Q1 14	($0.07)	($0.07)	$0.95 million	$0.81 million	View	N/A
8/5/2013	Q4 2013	($0.90)	($0.80)	$1.11 million	$0.87 million	View	N/A
4/30/2013	Q3 2013	($1.10)	($1.00)	$0.93 million	$0.87 million	View	N/A
1/31/2013	Q2 2013	($1.00)	($1.10)			View	N/A
11/5/2012	Q113	($0.10)	($0.11)	$1.05 million		View	N/A
8/2/2012	Q4 2012	($1.00)	($0.99)			View	N/A
5/1/2012	Q3 2012	($1.00)	($1.17)			View	N/A
2/6/2012	Q2 2012	($1.30)	($1.18)			View	N/A
10/27/2011	Q1 2012	($1.20)	($1.14)			View	N/A
8/9/2011	Q4 2011	($1.30)	($1.06)			View	N/A
5/10/2011	Q3 2011	($1.10)	($1.38)			View	N/A
1/27/2011	Q2 2011	($1.10)	($1.31)			View	N/A
11/11/2010	Q1 2011	($1.30)	$2.40			View	N/A
8/17/2010	Q4 2010	($1.20)	($1.27)			View	N/A
5/4/2010	Q3 2010	($1.00)	($1.24)			View	N/A
1/28/2010	Q2 2010	($1.10)	($0.93)			View	N/A
10/29/2009	Q1 2010	($1.70)	($1.69)			View	N/A
8/13/2009	Q4 2009	($2.30)	($2.19)			View	N/A
5/4/2009	Q3 2009	($2.70)	($2.47)			View	N/A
1/29/2009	Q2 2009	($3.20)	($2.98)			View	N/A
10/28/2008	Q1 2009	($3.10)	($3.27)			View	N/A
8/5/2008	Q4 2008	($2.70)	($3.08)			View	N/A
4/29/2008	Q3 2008		($3.55)			View	N/A
1/24/2008	Q2 2008	($2.70)	($2.88)			View	N/A

(Earnings results data provided by Zacks Investment Research)

Dextera Surgical (NASDAQ:DXTR) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Dextera Surgical (NASDAQ DXTR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 10.43%
Institutional Ownership Percentage: 4.49%

Insider Trading History for Dextera Surgical (NASDAQ:DXTR)

Institutional Ownership by Quarter for Dextera Surgical (NASDAQ:DXTR)

Dextera Surgical (NASDAQ DXTR) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/16/2016	Thomas J Palermo	COO	Buy	6,300	$2.62	$16,506.00	8,100
2/29/2016	Michael A Bates	Director	Buy	35,400	$3.53	$124,962.00	74,600
2/26/2016	Thomas J Palermo	COO	Buy	7,500	$3.77	$28,275.00	7,500
2/24/2016	Michael A Bates	Director	Buy	26,600	$2.99	$79,534.00	23,000
2/23/2016	Julian Nikolchev	Insider	Buy	1,146	$2.60	$2,979.60	6,464
2/23/2016	Michael A Bates	Director	Buy	5,000	$2.63	$13,150.00	23,000
2/22/2016	Julian Nikolchev	Insider	Buy	2,696	$2.60	$7,009.60	6,464
2/22/2016	Michael A Bates	Director	Buy	2,000	$2.62	$5,240.00	23,000
2/19/2016	Michael A Bates	Director	Buy	1,000	$2.53	$2,530.00	21,000
2/12/2016	Robert Y. Iv Newell	CFO	Buy	40,000	$0.26	$10,400.00
2/11/2016	Julian Nikolchev	Insider	Buy	37,680	$0.27	$10,173.60	37,680
2/9/2016	Gregory P Watson	VP	Buy	75,000	$0.25	$18,750.00	75,000
11/24/2014	Gary S Petersmeyer	Director	Buy	25,000	$0.60	$15,000.00
11/24/2014	Robert Y Iv Newell	CFO	Buy	20,000	$0.60	$12,000.00
11/13/2014	Robert Y Iv Newell	CFO	Buy	10,000	$0.87	$8,700.00
11/10/2014	William H Younger Jr	Director	Buy	34,354	$0.91	$31,262.14
5/23/2014	Jeffrey Purvin	Director	Buy	5,000	$0.95	$4,750.00
5/22/2014	Robert Y Iv Newell	CFO	Buy	10,000	$0.95	$9,500.00
11/21/2013	Bernard A Hausen	CEO	Buy	5,500	$0.95	$5,225.00
11/18/2013	Robert Y Iv Newell	CFO	Buy	10,000	$0.95	$9,500.00
3/20/2013	Hill Ventures Sutter	Major Shareholder	Buy	981,736	$1.05	$1,030,822.80
3/20/2013	Robert Y Iv Newell	CFO	Buy	8,000	$1.05	$8,400.00
3/20/2013	William H Younger Jr	Director	Buy	1,244,678	$1.05	$1,306,911.90

(Data available from 1/1/2013 forward)

Dextera Surgical (NASDAQ DXTR) News Headlines

Source:

Date	Headline
	Dextera Surgical Inc (DXTR) Receives Consensus Recommendation of "Hold" from Analysts www.americanbankingnews.com - April 10 at 11:21 PM
	Comparing Dextera Surgical (DXTR) & Nanosphere (NSPH) www.americanbankingnews.com - March 30 at 9:20 PM
	Head-To-Head Survey: Cynosure (CYNO) & Dextera Surgical (DXTR) www.americanbankingnews.com - March 30 at 5:21 AM
	Critical Survey: Dextera Surgical (DXTR) versus Alliance HealthCare Services (AIQ) www.americanbankingnews.com - March 26 at 9:32 AM
	Comparing Zeltiq Aesthetics (ZLTQ) & Dextera Surgical (DXTR) www.americanbankingnews.com - March 20 at 11:20 PM
	Analyzing Cynosure (CYNO) and Dextera Surgical (DXTR) www.americanbankingnews.com - March 19 at 5:16 PM
	Dextera Surgical Inc (DXTR) Given Consensus Rating of "Hold" by Analysts www.americanbankingnews.com - March 18 at 3:14 AM
	Financial Contrast: Dextera Surgical (DXTR) vs. Koninklijke Philips (PHG) www.americanbankingnews.com - March 17 at 3:06 AM
	Dextera Surgical Obtains Approval for Asset Sale to Aesculap, Inc. finance.yahoo.com - February 5 at 9:25 AM
	[$$] Aesculap to Acquire Bankrupt Surgical Stapler Maker Dextera finance.yahoo.com - January 23 at 10:33 AM
	Zacks: Dextera Surgical Inc (DXTR) Given Consensus Recommendation of "Hold" by Analysts www.americanbankingnews.com - January 23 at 5:06 AM
	Analyzing Accelerate Diagnostics (AXDX) & Dextera Surgical (DXTR) www.americanbankingnews.com - January 19 at 9:34 PM
	Dextera Surgical Inc (DXTR) Given Average Rating of "Hold" by Brokerages www.americanbankingnews.com - January 18 at 9:36 PM
	[$$] Firm Retention Summary: Dextera Surgical Inc. finance.yahoo.com - January 9 at 9:22 AM
	Dextera Surgical Inc (DXTR) Given $0.40 Consensus Target Price by Analysts www.americanbankingnews.com - December 24 at 1:28 AM
	Dextera Surgical (DXTR) & Luminex (LMNX) Head to Head Survey www.americanbankingnews.com - December 22 at 1:24 PM
	Dextera Surgical (DXTR) Files for Chapter 11 Bankruptcy www.streetinsider.com - December 13 at 9:35 AM
	Dextera Surgical (DXTR) Rating Increased to Hold at Zacks Investment Research www.americanbankingnews.com - December 12 at 9:28 PM
	Dextera Surgical Files For Bankruptcy - Quick Facts www.nasdaq.com - December 12 at 5:57 PM
	[$$] Dextera Surgical Files for Bankruptcy With $17.3 Million Buyout Offer From Aesculap finance.yahoo.com - December 12 at 5:57 PM
	Dextera Surgical (DXTR) Files for Chapter 11 Bankruptcy - StreetInsider.com www.streetinsider.com - December 12 at 9:48 AM
	Zacks: Analysts Anticipate Dextera Surgical Inc (DXTR) to Announce -$0.06 EPS www.americanbankingnews.com - December 7 at 3:36 PM
	Reviewing Dextera Surgical (DXTR) & Thoratec (THOR) www.americanbankingnews.com - December 3 at 11:40 PM
	Breakfast Technical Briefing on Medical Supplies Stocks -- Endologix, Dextera Surgical, Becton, Dickinson, and Ekso Bionics www.bizjournals.com - November 21 at 6:17 PM
	$880,000.00 in Sales Expected for Dextera Surgical Inc. (DXTR) This Quarter www.americanbankingnews.com - November 21 at 6:46 AM
	-$0.06 EPS Expected for Dextera Surgical Inc. (DXTR) This Quarter www.americanbankingnews.com - November 19 at 7:12 PM
	Dextera Surgical Inc. (DXTR) Sees Significant Decrease in Short Interest www.americanbankingnews.com - November 12 at 1:32 AM
	Dextera Surgical Inc. (DXTR) Releases Earnings Results, Misses Expectations By $0.02 EPS www.americanbankingnews.com - November 10 at 7:32 PM
	Dextera Surgical, Inc. to Host Earnings Call finance.yahoo.com - November 10 at 11:34 AM
	Dextera Surgical Reports Fiscal 2018 First Quarter Financial Results finance.yahoo.com - November 10 at 11:34 AM
	Dextera Surgical to Cancel Fiscal 2018 First Quarter Financial Results Conference Call on Thursday November 9, 2017 finance.yahoo.com - November 9 at 1:22 AM
	Why Dextera Surgical Inc’s (DXTR) Investor Composition Impacts Your Returns finance.yahoo.com - November 3 at 6:29 PM
	Zacks: Brokerages Anticipate Dextera Surgical Inc. (DXTR) Will Announce Quarterly Sales of $620,000.00 www.americanbankingnews.com - November 1 at 2:32 PM
	Dextera Surgical to Announce Fiscal 2018 First Quarter Financial Results on Thursday November 9, 2017 finance.yahoo.com - October 30 at 6:47 PM
	Dextera Surgical Inc. (DXTR) to Release Quarterly Earnings on Monday www.americanbankingnews.com - October 30 at 9:14 AM
	MedTech Growing on Emerging Markets, M&A: Stocks to Buy finance.yahoo.com - October 25 at 7:47 PM
	Tech Stocks to Keep on Your Radar finance.yahoo.com - October 20 at 7:35 PM
	Dextera Surgical (DXTR) & Its Peers Critical Analysis www.americanbankingnews.com - October 17 at 10:36 AM
	Dextera Surgical Inc. (DXTR) Expected to Post Quarterly Sales of $620,000.00 www.americanbankingnews.com - October 13 at 1:48 PM
	Brokers Set Expectations for Dextera Surgical Inc.'s FY2018 Earnings (DXTR) www.americanbankingnews.com - October 12 at 1:54 PM
	Zacks: Analysts Anticipate Dextera Surgical Inc. (DXTR) Will Announce Earnings of -$0.06 Per Share www.americanbankingnews.com - October 11 at 4:30 AM
	Dextera Surgical Inc. (DXTR) Upgraded to "Hold" by Zacks Investment Research www.americanbankingnews.com - October 11 at 12:04 AM
	Dextera Surgical (DXTR) Says MicroCutter 5/80 and Cardiac Anastomotic Devices to Be Featured at EACTS www.streetinsider.com - October 10 at 6:14 AM
	Reviewing Dextera Surgical (DXTR) & Varian Medical Systems (VAR) www.americanbankingnews.com - October 10 at 4:28 AM
	Dextera Surgical (DXTR) Says MicroCutter 5/80 and Cardiac Anastomotic Devices to Be Featured at EACTS - StreetInsider.com www.streetinsider.com - October 9 at 6:27 PM
	Dextera Surgical’s MicroCutter 5/80™ and Cardiac Anastomotic Devices to Be Featured at the 31st Annual European Association for Cardio-Thoracic Surgery finance.yahoo.com - October 9 at 6:27 PM
	Dextera Surgical (DXTR) Says it Working to Resolve Issues; Plans to Explore All Strategic Options - StreetInsider.com www.streetinsider.com - October 7 at 3:42 PM
	Edited Transcript of DXTR earnings conference call or presentation 5-Oct-17 12:30pm GMT finance.yahoo.com - October 5 at 10:18 PM
	Dextera Surgical Inc. (DXTR) Sees Large Increase in Short Interest www.americanbankingnews.com - September 30 at 3:26 AM
	Dextera Surgical Hosts Hands-on Training Course for Video-Assisted Thoracic Surgery Techniques Using MicroCutter ... - Business Wire (press release) www.businesswire.com - September 28 at 9:04 AM

Dextera Surgical (NASDAQ:DXTR) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Dextera Surgical (NASDAQ:DXTR) Income Statement, Balance Sheet and Cash Flow Statement

Dextera Surgical (NASDAQ DXTR) Stock Chart for Friday, April, 20, 2018

Loading chart…

This page was last updated on 4/20/2018 by MarketBeat.com Staff